Literature DB >> 32611575

NUP98 and KMT2A: usually the bride rather than the bridesmaid.

Alexandre Fagnan1,2,3, Thomas Mercher1,2,3,4.   

Abstract

Entities:  

Year:  2020        PMID: 32611575      PMCID: PMC7327639          DOI: 10.3324/haematol.2020.253476

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  20 in total

1.  Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias.

Authors:  Chi Wai So; Min Lin; Paul M Ayton; Everett H Chen; Michael L Cleary
Journal:  Cancer Cell       Date:  2003-08       Impact factor: 31.743

2.  Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction.

Authors:  Angeliki Thanasopoulou; Alexandar Tzankov; Juerg Schwaller
Journal:  Haematologica       Date:  2014-06-20       Impact factor: 9.941

Review 3.  NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights.

Authors:  Sheryl M Gough; Christopher I Slape; Peter D Aplan
Journal:  Blood       Date:  2011-09-26       Impact factor: 22.113

4.  Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor.

Authors:  Scott R Daigle; Edward J Olhava; Carly A Therkelsen; Christina R Majer; Christopher J Sneeringer; Jeffrey Song; L Danielle Johnston; Margaret Porter Scott; Jesse J Smith; Yonghong Xiao; Lei Jin; Kevin W Kuntz; Richard Chesworth; Mikel P Moyer; Kathrin M Bernt; Jen-Chieh Tseng; Andrew L Kung; Scott A Armstrong; Robert A Copeland; Victoria M Richon; Roy M Pollock
Journal:  Cancer Cell       Date:  2011-07-12       Impact factor: 31.743

5.  NUP98-MLL fusion in human acute myeloblastic leukemia.

Authors:  Sophie Kaltenbach; Gwendoline Soler; Carole Barin; Carine Gervais; Olivier A Bernard; Virginie Penard-Lacronique; Serge P Romana
Journal:  Blood       Date:  2010-06-17       Impact factor: 22.113

6.  NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis.

Authors:  S Struski; S Lagarde; P Bories; C Puiseux; N Prade; W Cuccuini; M-P Pages; A Bidet; C Gervais; M Lafage-Pochitaloff; C Roche-Lestienne; C Barin; D Penther; N Nadal; I Radford-Weiss; M-A Collonge-Rame; B Gaillard; F Mugneret; C Lefebvre; E Bart-Delabesse; A Petit; G Leverger; C Broccardo; I Luquet; M Pasquet; E Delabesse
Journal:  Leukemia       Date:  2016-10-03       Impact factor: 11.528

7.  MLL-AF9 Expression in Hematopoietic Stem Cells Drives a Highly Invasive AML Expressing EMT-Related Genes Linked to Poor Outcome.

Authors:  Vaia Stavropoulou; Susanne Kaspar; Laurent Brault; Mathijs A Sanders; Sabine Juge; Stefano Morettini; Alexandar Tzankov; Michelina Iacovino; I-Jun Lau; Thomas A Milne; Hélène Royo; Michael Kyba; Peter J M Valk; Antoine H F M Peters; Juerg Schwaller
Journal:  Cancer Cell       Date:  2016-06-23       Impact factor: 31.743

8.  Functional interdependence of BRD4 and DOT1L in MLL leukemia.

Authors:  Omer Gilan; Enid Y N Lam; Isabelle Becher; Dave Lugo; Ester Cannizzaro; Gerard Joberty; Aoife Ward; Meike Wiese; Chun Yew Fong; Sarah Ftouni; Dean Tyler; Kym Stanley; Laura MacPherson; Chen-Fang Weng; Yih-Chih Chan; Margherita Ghisi; David Smil; Christopher Carpenter; Peter Brown; Neil Garton; Marnie E Blewitt; Andrew J Bannister; Tony Kouzarides; Brian J P Huntly; Ricky W Johnstone; Gerard Drewes; Sarah-Jane Dawson; Cheryl H Arrowsmith; Paola Grandi; Rab K Prinjha; Mark A Dawson
Journal:  Nat Struct Mol Biol       Date:  2016-06-13       Impact factor: 15.369

9.  A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia.

Authors:  Andrei V Krivtsov; Kathryn Evans; Jayant Y Gadrey; Benjamin K Eschle; Charlie Hatton; Hannah J Uckelmann; Kenneth N Ross; Florian Perner; Sarah N Olsen; Tara Pritchard; Lisa McDermott; Connor D Jones; Duohui Jing; Ali Braytee; Diego Chacon; Eric Earley; Brian M McKeever; David Claremon; Andrew J Gifford; Heather J Lee; Beverly A Teicher; John E Pimanda; Dominik Beck; Jennifer A Perry; Malcolm A Smith; Gerard M McGeehan; Richard B Lock; Scott A Armstrong
Journal:  Cancer Cell       Date:  2019-12-09       Impact factor: 31.743

10.  Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD).

Authors:  Q-Y Sun; L-W Ding; K-T Tan; W Chien; A Mayakonda; D-C Lin; X-Y Loh; J-F Xiao; M Meggendorfer; T Alpermann; M Garg; S-L Lim; V Madan; N Hattori; Y Nagata; S Miyano; A E J Yeoh; H-A Hou; Y-Y Jiang; S Takao; L-Z Liu; S-Z Tan; M Lill; M Hayashi; A Kinoshita; H M Kantarjian; S M Kornblau; S Ogawa; T Haferlach; H Yang; H P Koeffler
Journal:  Leukemia       Date:  2016-06-08       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.